rs13337470
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_024006.6(VKORC1):c.173+486C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,263,550 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0052 ( 8 hom., cov: 31)
Exomes 𝑓: 0.00055 ( 6 hom. )
Consequence
VKORC1
NM_024006.6 intron
NM_024006.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.129
Publications
4 publications found
Genes affected
VKORC1 (HGNC:23663): (vitamin K epoxide reductase complex subunit 1) This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
VKORC1 Gene-Disease associations (from GenCC):
- vitamin K-dependent clotting factors, combined deficiency of, type 2Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- vitamin K-dependent clotting factors, combined deficiency of, type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00521 (792/152156) while in subpopulation AFR AF = 0.0185 (769/41518). AF 95% confidence interval is 0.0174. There are 8 homozygotes in GnomAd4. There are 383 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR,Unknown gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VKORC1 | NM_024006.6 | c.173+486C>A | intron_variant | Intron 1 of 2 | ENST00000394975.3 | NP_076869.1 | ||
| VKORC1 | NM_001311311.2 | c.173+486C>A | intron_variant | Intron 1 of 3 | NP_001298240.1 | |||
| VKORC1 | NM_206824.3 | c.173+486C>A | intron_variant | Intron 1 of 1 | NP_996560.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00520 AC: 790AN: 152038Hom.: 8 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
790
AN:
152038
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000551 AC: 612AN: 1111394Hom.: 6 Cov.: 15 AF XY: 0.000476 AC XY: 263AN XY: 552014 show subpopulations
GnomAD4 exome
AF:
AC:
612
AN:
1111394
Hom.:
Cov.:
15
AF XY:
AC XY:
263
AN XY:
552014
show subpopulations
African (AFR)
AF:
AC:
542
AN:
25840
American (AMR)
AF:
AC:
15
AN:
27990
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
18330
East Asian (EAS)
AF:
AC:
0
AN:
37470
South Asian (SAS)
AF:
AC:
1
AN:
65076
European-Finnish (FIN)
AF:
AC:
0
AN:
34100
Middle Eastern (MID)
AF:
AC:
1
AN:
4742
European-Non Finnish (NFE)
AF:
AC:
10
AN:
849808
Other (OTH)
AF:
AC:
43
AN:
48038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00521 AC: 792AN: 152156Hom.: 8 Cov.: 31 AF XY: 0.00515 AC XY: 383AN XY: 74380 show subpopulations
GnomAD4 genome
AF:
AC:
792
AN:
152156
Hom.:
Cov.:
31
AF XY:
AC XY:
383
AN XY:
74380
show subpopulations
African (AFR)
AF:
AC:
769
AN:
41518
American (AMR)
AF:
AC:
17
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4
AN:
68008
Other (OTH)
AF:
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
37
74
111
148
185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.